Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II, Multicentre, Randomised, Placebo-controlled, Doublemasked Trial of RP101 Ophthalmic Formulation Versus Vehicle in Post-menopausal Women With Moderate to Severe Dry Eye Syndrome

Next Previous
Trial Profile

A Phase II, Multicentre, Randomised, Placebo-controlled, Doublemasked Trial of RP101 Ophthalmic Formulation Versus Vehicle in Post-menopausal Women With Moderate to Severe Dry Eye Syndrome

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Nov 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs RP 101-Redwood Pharma (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Sponsors Redwood Pharma

    • Most Recent Events

    • 12 Nov 2019 According to a Redwood Pharma media release, last patient received their last dose, Thus, the treatment phase in the clinical trial is finished. Company is now working on collecting and quality-assuring the extensive material in order to then analyze the results.
    • 05 Aug 2019 Status changed from recruiting to active, no longer recruiting.
    • 05 Aug 2019 According to a Redwood Pharma media release, approximately 100 patients are evaluated during a treatment period of three months, after which the study ends with a follow-up after the last dose has been administered. Topline results are expected to be published no later than the first quarter of 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top